Daptomycin
- Product NDC
- 45932-0039
- 11-digit product format
- 459320039
- Labeler code
- 45932
- Product ID
- 45932-0039_124c90b9-3a96-4e66-9818-8088cd70cd86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Xellia Pharmaceuticals USA, LLC
- Application
- NDA209949
- Marketing category
- NDA
- Marketing start
- 2018-07-19
- Marketing end
- 0000-00-00
- Substance
- DAPTOMYCIN
- Active strength
- 350 mg/7mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC],Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45932-0039-1 | Daptomycin | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 9 |
| 45932-0039-1 | Daptomycin | 7 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 7 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45932-0039 | DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [XELLIA PHARMACEUTICALS USA, LLC] | 9 | Legacy NDC, 2 package rows | 20191007_e3e6b91e-c673-46da-a654-2bb1312cb02b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 45932-0039-1 | 45932003901 | 1 in 1 CARTON | Historical |